Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

HYG vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, HYG returned +1.3% to IBB's +37.5%, and IBB charges 0.44% to HYG's 0.49%.

askIQ about this page

askIQ about HYG and IBB

Net assets on Oct 27, 2026: $17.5bn for iShares iBoxx $ High Yield Corporate Bond ETF and $11.0bn for iShares Biotechnology ETF.

At a glance
+1.3%
HYG total return, 1 year
+37.5%
IBB total return, 1 year
0.49%
HYG expense ratio
0.44%
IBB expense ratio

Pair scorecard

IBB costs 0.05 points a year less; their one-year returns differ by 36.2 points; HYG is 1.6 times larger.

HYG vs IBB: Differences, Returns & Fees
MeasureHYGIBB
Return
Total return, 1 year+1.3%+37.5%
Benchmark
What it tracksMarkit iBoxx USD Liquid High Yield IndexBiotech
Cost and size
Expense ratio0.49%0.44%
Net assets, as of Oct 27, 2026$17.5bn$11.0bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, HYG and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first HYG IBB
Only in one fund ↓
Only in HYG
1261229 BC LTD 144A 0.56%
MERIDIAN ARC HOLDCO LLC 144A 0.44%
ECHOSTAR CORP 0.40%
QUIKRETE HOLDINGS INC 144A 0.35%
PR RNO PROPERTY OWNER 1 LLC 144A 0.34%
CLOUD SOFTWARE GROUP LLC 144A 0.32%
SOFTBANK GROUP CORP 144A 0.32%
CENTENE CORPORATION 0.31%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

HYG iShares iBoxx $ High Yield Corporate Bond ETF IBB iShares Biotechnology ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of US high yield bonds Biotech
Total return, 1 year +1.3% +37.5%
Its benchmark over the same days −1.2% (IUSB) not measured
Gap to its benchmark +2.5 pts vs IUSB not measured
Expense ratio 0.49% 0.44%
Holdings 1332 245
Net assets, as of Oct 27, 2026 $17.5bn $11.0bn

HYG and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

HYG and IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
HYG

HYG tracks an index of US high yield bonds. Over the year to Oct 28, 2026 it returned +1.3% with distributions reinvested, against −1.2% for its benchmark, the Bloomberg U.S. Universal Index. The prospectus expense ratio is 0.49% a year.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are HYG and IBB in the same category?
HYG is a bond ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, HYG or IBB?
In the year to Oct 28, 2026, with distributions reinvested, HYG returned +1.3% and IBB +37.5%.
Which is cheaper, HYG or IBB?
IBB is cheaper, by 0.05 percentage points a year. That is about $5 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, HYG against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/hyg-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.